Early Tracheotomy for Switching Between Invasive and Noninvasive Ventilation to Facilitate Weaning
Efficacy and Safety of Early Tracheotomy for Switching Between Invasive and Noninvasive Ventilation to Facilitate Weaning: a Randomized Control Trial
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Guosheng Ren, MD
- Phone Number: 02389012680
Study Locations
-
-
Chongqing Municipality
-
Chongqing, Chongqing Municipality, China, 400016
- The first affiated hospital, chongqing medical university
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- duration of invasive ventilation 5 to 7 days
- anticipation of difficult weaning
- Glasgow Coma Scale ≥13
- no upper airway obstruction
- presence of spontaneous breath
Exclusion Criteria:
- age less than 18 or more than 85 years;
- contraindications for noninvasive ventilation;
- anticipation of survival less than 6 months;
- refusal of tracheotomy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Intervention group
Patients in this group are received ventilator weaning by switching between invasive and noninvasive ventilation.
|
As defined criteria, patients are switched between invasive and noninvasive ventilation until the ventilator is successfully weaned.
|
|
No Intervention: Control group
Patients in this group are weaned from ventilator as conventional methods.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
ventilator weaning days
Time Frame: from enrollment to 90 days
|
from enrollment to 90 days
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
successful weaning rate
Time Frame: from enrollment to 90 days
|
from enrollment to 90 days
|
|
ICU stay days
Time Frame: from admission to 90 days
|
from admission to 90 days
|
|
hospital stay days
Time Frame: from admission to 90 days
|
from admission to 90 days
|
|
ICU mortality
Time Frame: from admission to 90 days
|
from admission to 90 days
|
|
hospital mortality
Time Frame: from admission to 90 days
|
from admission to 90 days
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Shuliang Guo, MD, First Affiliated Hospital of Chongqing Medical University
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimated)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- cqykdxfsdyyy3
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.